<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet type='text/xsl' href='https://drugreporter.com/wp-content/plugins/google-sitemap-generator/sitemap.xsl'?><!-- sitemap-generator-url='http://www.arnebrachhold.de' sitemap-generator-version='4.1.23' -->
<!-- generated-on='April 29, 2026 11:55 am' -->
<urlset xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd' xmlns='http://www.sitemaps.org/schemas/sitemap/0.9'>	<url>
		<loc>https://drugreporter.com/2014/05/bleeding-problems-pradaxa-xarelto-highlighted-in-new-report/</loc>
		<lastmod>2014-10-03T16:12:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/counsel-takeda-pharmaceuticals-face-sanctions-actos-trial/</loc>
		<lastmod>2014-08-12T20:29:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/more-100-plaintiffs-file-yaz-birth-control-lawsuit-illinois/</loc>
		<lastmod>2015-04-24T15:56:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/coordination-testosterone-therapy-lawsuits-split-decision/</loc>
		<lastmod>2014-08-12T20:28:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/study-finds-link-between-benicar-and-celiac-like-symptoms/</loc>
		<lastmod>2014-08-12T20:27:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/fda-releases-updated-statement-pradaxa-stomach-bleed-risk/</loc>
		<lastmod>2014-10-03T16:12:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/mdl-zoloft-lawsuit-trial-delayed/</loc>
		<lastmod>2014-08-12T20:26:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/doctors-group-launches-offensive-stronger-fda-warnings-testosterone-drugs/</loc>
		<lastmod>2014-08-12T20:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/05/las-vegas-actos-trial-ends-defense-verdict/</loc>
		<lastmod>2014-08-12T20:24:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/650-million-settlement-reached-thousands-pradaxa-lawsuits/</loc>
		<lastmod>2014-10-03T16:11:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/bacterial-contamination-prompts-expanded-naturalyte-recall/</loc>
		<lastmod>2014-08-12T20:20:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/testosterone-drug-side-effects-give-rise-class-action-lawsuit/</loc>
		<lastmod>2014-08-12T20:20:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/jj-petitions-judge-dismiss-risperdal-lawsuits-based-statute-limitations/</loc>
		<lastmod>2014-08-12T20:19:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/research-sheds-light-benicar-side-effects-diabetes-risk/</loc>
		<lastmod>2014-08-12T20:11:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/testosterone-therapy-lawsuits-centralized/</loc>
		<lastmod>2014-08-12T20:10:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/06/blue-crossblue-shield-sue-takeda-actos-manufacturer/</loc>
		<lastmod>2014-08-12T20:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/childhood-obesity-study-linked-ssri-pregnancy-side-effects/</loc>
		<lastmod>2014-08-12T20:09:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/takeda-seeks-trial-actos-bladder-cancer-lawsuit-verdict/</loc>
		<lastmod>2014-08-12T20:08:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/zoloft-birth-defects-lawsuits-face-setback-mdl/</loc>
		<lastmod>2014-08-12T20:08:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/father-files-propecia-cognitive-dysfunction-lawsuit-behalf-dead-son/</loc>
		<lastmod>2014-08-12T19:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/yaz-lawsuit-alleges-pill-caused-pulmonary-embolism/</loc>
		<lastmod>2014-08-12T19:52:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/french-study-supports-claims-benicar-gi-side-effects-lawsuits/</loc>
		<lastmod>2014-08-12T19:17:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/fda-calls-advisory-committees-recommend-action-low-t-drugs/</loc>
		<lastmod>2014-08-12T19:49:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/07/monitoring-dosing-adjustments-minimize-pradaxa-bleeding-events-investigation-finds/</loc>
		<lastmod>2014-10-03T16:11:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/08/drug-maker-takeda-facing-sanctions-misconduct-actos-cancer-lawsuits/</loc>
		<lastmod>2014-08-12T19:48:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/08/ma-widow-files-januvia-cancer-lawsuit-against-merck/</loc>
		<lastmod>2014-08-12T19:46:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/08/bayer-settles-thousands-yaz-lawsuits/</loc>
		<lastmod>2014-08-12T19:46:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/08/zoloft-mdl-judge-remands-birth-defects-case-back-missouri-state-court/</loc>
		<lastmod>2014-08-18T19:46:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/08/astrazeneca-settles-84-byetta-cases-more-pending/</loc>
		<lastmod>2014-08-22T20:58:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/08/tennessee-family-seeks-10-million-xarelto-fatal-bleed-lawsuit/</loc>
		<lastmod>2014-08-28T20:12:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/alabama-supreme-court-rules-brand-name-drug-makers-liable-generic-version-injuries/</loc>
		<lastmod>2014-09-02T15:46:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/new-study-uncovers-link-between-risperdal-gynecomastia/</loc>
		<lastmod>2014-09-05T20:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/9-billion-punitive-actos-lawsuit-award-upheld/</loc>
		<lastmod>2014-09-09T13:32:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/federal-yaz-yasmin-lawsuits-prepare-trial/</loc>
		<lastmod>2014-09-16T00:34:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/preliminary-discovery-plan-outlined-low-t-drug-lawsuits/</loc>
		<lastmod>2014-09-16T22:03:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/propecia-lawsuit-lists-cancer-among-plaintiffs-complications/</loc>
		<lastmod>2014-09-22T00:23:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/fda-panel-backs-new-testosterone-drug-safety-limits/</loc>
		<lastmod>2014-09-23T21:58:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/new-lipitor-diabetes-lawsuit-joins-mdl/</loc>
		<lastmod>2014-09-29T17:33:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/09/actos-class-action-lawsuit-filed-health-care-fund/</loc>
		<lastmod>2014-09-30T21:17:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/first-bellwether-trial-set-lipitor-diabetes-lawsuits-consolidated-under-mdl-2502/</loc>
		<lastmod>2014-10-05T20:44:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/talcum-powder-cancer-lawsuit-remanded-circuit-court/</loc>
		<lastmod>2014-10-08T02:35:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/januvia-pancreatic-cancer-lawsuit-joins-federal-mdl/</loc>
		<lastmod>2014-10-10T21:51:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/pa-woman-nets-2-million-actos-lawsuit-award/</loc>
		<lastmod>2014-10-14T21:14:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/xarelto-bleeding-side-effects-lawsuit-filed-california/</loc>
		<lastmod>2014-10-17T20:46:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/xarelto-lawsuits-may-be-headed-mdl/</loc>
		<lastmod>2014-10-22T03:28:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/risperdal-gynecomastia-lawsuits-poised-trial/</loc>
		<lastmod>2014-10-25T02:45:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/10/microbial-contamination-leads-xarelto-recall/</loc>
		<lastmod>2014-10-31T13:25:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/11/us-jpml-hear-oral-arguments-regarding-xarelto-mdl/</loc>
		<lastmod>2014-11-04T18:26:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/11/ruling-permits-plaintiffs-file-testosterone-lawsuits-directly-mdl/</loc>
		<lastmod>2014-11-10T23:01:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/11/mdl-judge-reduces-9-billion-actos-lawsuit-award/</loc>
		<lastmod>2014-11-11T22:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/11/new-study-suggests-talcum-powder-mesothelioma-link/</loc>
		<lastmod>2014-11-14T20:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/11/study-shows-benicar-linked-severe-abdominal-problems/</loc>
		<lastmod>2014-11-20T22:35:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/11/research-safer-alternatives-statins/</loc>
		<lastmod>2014-11-26T02:30:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/judge-concludes-takeda-destroyed-files-actos-bladder-cancer-lawsuit/</loc>
		<lastmod>2014-12-01T14:27:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/ema-study-highlights-testosterone-drug-risks/</loc>
		<lastmod>2014-12-02T18:24:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/late-2016-trial-dates-federal-propecia-lawsuits/</loc>
		<lastmod>2014-12-06T03:25:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/effexor-birth-defect-trials-move-forward/</loc>
		<lastmod>2014-12-09T18:26:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/risperdal-gynecomastia-lawsuit-filed-louisiana-district-court/</loc>
		<lastmod>2014-12-12T19:06:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/study-shows-xarelto-bleeding-risks-equivalent-warfarin/</loc>
		<lastmod>2014-12-20T00:41:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/yaz-lawsuits-headed-trial/</loc>
		<lastmod>2014-12-23T23:17:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/xarelto-lawsuits-consolidated-multi-district-litigation/</loc>
		<lastmod>2014-12-29T22:46:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2014/12/benicar-lawsuits-centralized-under-mdl/</loc>
		<lastmod>2014-12-30T23:13:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/judge-determines-bellwether-process-non-androgel-testosterone-injury-lawsuits/</loc>
		<lastmod>2015-01-06T22:53:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/new-fresenius-dialysis-lawsuit-joins-mdl-2428/</loc>
		<lastmod>2015-01-09T18:08:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/propecia-side-effects-persist-according-new-lawsuit/</loc>
		<lastmod>2015-01-12T21:16:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/risperdal-lawsuit-gynecomastia-filed-louisiana/</loc>
		<lastmod>2015-01-12T22:42:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/byetta-lawsuit-alleges-diabetes-drug-caused-thyroid-cancer/</loc>
		<lastmod>2015-01-16T02:37:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/judge-gives-green-light-conspiracy-claim-talcum-powder-lawsuit/</loc>
		<lastmod>2015-01-16T19:54:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/whistle-blowing-ex-employee-daiichi-sankyo-victorious-39-million-benicar-settlement/</loc>
		<lastmod>2015-01-19T18:15:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/new-study-reveals-testosterone-drug-risk/</loc>
		<lastmod>2015-01-21T17:30:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/zoloft-plaintiffs-mdl-get-second-chance-expert-witness/</loc>
		<lastmod>2015-01-23T20:20:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/new-xarelto-bleeding-lawsuit-filed-california/</loc>
		<lastmod>2015-01-27T03:49:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/xarelto-bleed-victims-join-mass-tort-philadelphia/</loc>
		<lastmod>2015-01-30T04:28:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/01/federal-judge-orders-coordination-state-actos-lawsuits/</loc>
		<lastmod>2015-02-03T04:56:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/californian-joins-mdl-linking-naturalyte-granuflo-sudden-cardiac-arrest/</loc>
		<lastmod>2015-02-03T21:21:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/risperdal-lawsuit-claims-promotion-off-label-use/</loc>
		<lastmod>2015-02-04T17:19:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/deceptive-marketing-crux-androgel-lawsuit/</loc>
		<lastmod>2015-02-08T22:40:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/quarterwatch-reports-fdas-faers-system-recommends-changes/</loc>
		<lastmod>2015-02-12T17:28:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/unregulated-low-t-clinics-prescribe-testosterone-drug-future/</loc>
		<lastmod>2015-02-13T20:39:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/alabama-couple-files-baby-powder-cancer-lawsuit/</loc>
		<lastmod>2015-02-13T11:27:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/xarelto-lawsuits-gain-plaintiffs-steering-committee/</loc>
		<lastmod>2015-02-16T17:53:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/actos-bladder-cancer-lawsuit-filed-multiple-plaintiffs/</loc>
		<lastmod>2015-02-19T00:42:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/risperdal-lawsuit-filed-eastern-district-of-louisiana-court/</loc>
		<lastmod>2015-02-20T21:26:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/law-firm-files-risperdal-lawsuit-against-fda/</loc>
		<lastmod>2015-02-24T00:11:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/report-indicates-xarelto-clinical-trials-riddled-misconduct-fraud/</loc>
		<lastmod>2015-02-27T05:07:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/02/new-study-reveals-need-clinical-clarification-testosterone-side-effects/</loc>
		<lastmod>2015-02-28T01:42:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/jury-finds-link-between-risperdal-male-breast-growth-awards-2-5-million-verdict/</loc>
		<lastmod>2015-03-06T21:19:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/fda-warns-testosterone-heart-attack-risk-mandates-label-changes/</loc>
		<lastmod>2015-03-09T17:37:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/research-misconduct-involving-xarelto-goes-unreported/</loc>
		<lastmod>2015-03-10T19:40:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/new-study-explores-transplacental-transfer-zofran/</loc>
		<lastmod>2015-04-28T20:43:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/bayer-faces-xarelto-class-action-lawsuit-canada/</loc>
		<lastmod>2015-03-18T19:32:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/endocrine-society-examines-testosterone-heart-disease-risk/</loc>
		<lastmod>2015-03-22T19:51:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/axiron-lawsuit-filed-heart-attack-death/</loc>
		<lastmod>2015-03-23T22:28:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/minnesota-mother-files-zofran-lawsuit-over-birth-defects/</loc>
		<lastmod>2015-04-28T20:39:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/03/judge-schedules-actos-settlement-conferences-prior-bellwether-trials/</loc>
		<lastmod>2015-03-29T22:40:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/testosterone-heart-attack-lawsuit-filed-ga-couple/</loc>
		<lastmod>2015-03-30T19:34:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/jury-agrees-plaintiff-allegations-risperdal-case/</loc>
		<lastmod>2015-04-02T04:20:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/intracranial-hemorrhage-subject-xarelto-lawsuit/</loc>
		<lastmod>2015-04-03T12:58:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/2-2-billion-actos-settlement-offer-bargain-takeda/</loc>
		<lastmod>2015-04-08T18:57:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/baby-powder-cancer-lawsuit-dismissed-no-injuries-alleged-complaint/</loc>
		<lastmod>2015-04-10T21:10:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/zofran-lawsuit-filed-montana-district-court/</loc>
		<lastmod>2015-04-28T20:33:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/alabama-mother-files-zofran-lawsuit/</loc>
		<lastmod>2015-04-28T20:28:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/granuflo-lawsuit-filed-dialysis-patients-heart-attack/</loc>
		<lastmod>2015-04-15T18:46:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/lawsuit-questions-xarelto-safety/</loc>
		<lastmod>2015-04-17T19:13:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/jpml-denies-motion-centralize-testofen-lawsuits/</loc>
		<lastmod>2015-04-21T19:42:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/onglyza-heart-failure-concerns-prompt-recommendation-fda-panel/</loc>
		<lastmod>2015-04-22T19:05:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/risperdal-lawsuit-filed-louisiana-district-court/</loc>
		<lastmod>2015-04-25T00:51:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/two-women-file-zofran-lawsuits-alleging-birth-defects/</loc>
		<lastmod>2015-04-28T20:23:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/04/texas-man-claims-xarelto-caused-severe-gi-bleed/</loc>
		<lastmod>2015-04-29T17:37:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/granuflo-wrongful-death-claim-joins-mdl-2428/</loc>
		<lastmod>2015-05-05T21:40:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/2-4-billion-actos-settlement-announced/</loc>
		<lastmod>2015-05-04T18:52:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/study-pradaxa-xarelto-side-effects-shows-twofold-risk-bleeding-warfarin/</loc>
		<lastmod>2015-05-10T20:26:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/georgia-man-files-testosterone-drug-lawsuit/</loc>
		<lastmod>2015-05-08T17:58:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/california-couple-settles-talcum-powder-asbestos-case/</loc>
		<lastmod>2015-05-11T19:08:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/xarelto-lawsuit-alleges-severe-permanent-injuries/</loc>
		<lastmod>2015-05-13T18:47:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/lawsuit-claims-androgel-user-suffered-fatal-cardiac-arrest/</loc>
		<lastmod>2015-05-15T13:48:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/fda-clarify-position-off-label-uses-drugs/</loc>
		<lastmod>2016-01-07T18:23:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/discovery-phase-fresenius-dialysis-bellwether-lawsuits/</loc>
		<lastmod>2015-05-20T23:02:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/abbvie-looking-further-delay-androgel-lawsuits/</loc>
		<lastmod>2015-05-22T20:10:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/zofran-lawsuit-alleges-drug-caused-cleft-lip/</loc>
		<lastmod>2015-05-26T19:22:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/05/testosterone-side-effects-may-include-enlarged-prostate-study-finds/</loc>
		<lastmod>2015-05-28T19:53:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/jury-awards-15-million-depakote-birth-defects-case/</loc>
		<lastmod>2015-06-03T18:49:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/new-class-diabetes-drugs-subject-fda-warning/</loc>
		<lastmod>2015-06-03T22:14:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/new-xarelto-bleeding-injury-lawsuit-filed-nc-plaintiff/</loc>
		<lastmod>2015-06-04T02:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/phoenix-residents-file-actos-lawsuit-bladder-cancer/</loc>
		<lastmod>2015-06-05T18:15:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/xarelto-injury-lawsuit-alleges-wrongful-death/</loc>
		<lastmod>2015-06-12T19:09:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/fda-issues-invokana-side-effects-safety-communication/</loc>
		<lastmod>2015-06-15T17:57:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/androgel-testosterone-lawsuits-proceed-planned/</loc>
		<lastmod>2015-06-17T17:19:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/death-baby-prompts-zofran-lawsuit/</loc>
		<lastmod>2015-06-19T21:44:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/request-centralize-talc-powder-lawsuits/</loc>
		<lastmod>2015-06-22T16:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/australian-health-regulators-question-benefit-xarelto-monitoring/</loc>
		<lastmod>2015-06-23T20:56:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/is-low-t-real-condition-fda-weighs-in/</loc>
		<lastmod>2015-06-26T13:36:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/06/male-breast-reduction-surgery-risperdal-patients/</loc>
		<lastmod>2015-07-06T21:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/canadian-health-officials-evaluate-farxiga-invokana-risks/</loc>
		<lastmod>2015-07-22T18:11:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/zofran-lawsuit-alleges-drug-caused-babys-clubfoot/</loc>
		<lastmod>2015-07-06T21:15:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/widow-alleges-fresenius-responsible-husbands-death/</loc>
		<lastmod>2015-07-08T12:11:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/testosterone-lawsuit-alleges-plaintiff-suffered-pulmonary-embolism/</loc>
		<lastmod>2015-07-12T18:02:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/conference-review-possible-sglt2-inhibitor-side-effects/</loc>
		<lastmod>2015-07-13T17:49:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/gsk-seeks-consolidate-zofran-lawsuits-alleging-birth-defects/</loc>
		<lastmod>2015-07-15T18:04:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/consumer-advocacy-group-denounces-21st-century-cures-act/</loc>
		<lastmod>2015-07-17T19:17:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/zofran-birth-defect-lawsuit-accuses-gsk-misrepresentation/</loc>
		<lastmod>2015-07-20T17:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/study-blood-thinner-xarelto-may-cross-placental-barrier/</loc>
		<lastmod>2015-07-22T19:17:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/07/actos-lawsuit-alleges-negligent-concealment-cancer-risks/</loc>
		<lastmod>2015-07-24T13:16:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/plaintiffs-support-talcum-powder-cancer-lawsuits-mcl/</loc>
		<lastmod>2015-08-02T05:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/study-links-actos-increased-risk-pancreatic-prostate-cancers/</loc>
		<lastmod>2015-08-03T19:02:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/testosterone-injury-lawsuits-approach-2000-mark/</loc>
		<lastmod>2015-08-06T17:41:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/zofran-lawsuit-alleges-illegal-marketing-consumer-deception/</loc>
		<lastmod>2015-08-07T19:06:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/study-shows-adverse-drug-side-effects-reported-fda-right-away/</loc>
		<lastmod>2015-08-10T19:48:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/xarelto-lawsuit-alleges-severe-injuries-fatalities/</loc>
		<lastmod>2015-08-12T17:56:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/parents-file-zofran-birth-defects-lawsuit-north-dakota-district-court/</loc>
		<lastmod>2015-08-14T19:38:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/pradaxa-xarelto-bleeding-complications-similar-warfarin/</loc>
		<lastmod>2015-08-17T20:23:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/lawsuit-alleges-androgel-use-caused-multiple-strokes/</loc>
		<lastmod>2015-08-19T22:28:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/mother-says-gsk-deceived-public-zofran-birth-defects-son-permanently-injured/</loc>
		<lastmod>2015-08-25T17:49:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/does-testosterone-therapy-contribute-atherosclerosis/</loc>
		<lastmod>2015-08-25T17:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/granuflo-lawsuit-alleges-fatal-cardiac-event/</loc>
		<lastmod>2015-08-26T14:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/new-zofran-lawsuit-alleges-heart-abnormalities-due-to-drug/</loc>
		<lastmod>2015-08-29T02:07:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/08/janssen-accused-manipulating-published-risperdal-study/</loc>
		<lastmod>2015-08-31T14:54:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/fda-researchers-express-concerns-testosterone-therapy/</loc>
		<lastmod>2015-09-04T03:26:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/zofran-lawsuit-claims-drug-caused-babys-atrial-septal-defect/</loc>
		<lastmod>2015-09-04T20:13:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/new-actos-trial-underway-las-vegas/</loc>
		<lastmod>2015-09-08T15:55:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/study-finds-correlation-between-risperdal-gynecomastia/</loc>
		<lastmod>2015-09-13T22:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/report-highlights-diabetic-ketoacidosis-risk-factors-sglt2-inhibitor-patients/</loc>
		<lastmod>2015-09-14T21:54:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/study-examines-testosterone-dosage-heart-risks/</loc>
		<lastmod>2015-09-16T14:11:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/xarelto-internal-bleeding-lawsuit-adds-5-plaintiffs-mdl/</loc>
		<lastmod>2015-09-23T02:37:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/fda-updates-invokana-label-regarding-bone-fracture-risk/</loc>
		<lastmod>2015-09-21T18:16:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/actos-lawsuits-headed-mass-settlement/</loc>
		<lastmod>2015-09-24T16:03:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/study-finds-antidepressant-paxil-unsafe-teenagers/</loc>
		<lastmod>2015-09-26T20:28:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/fda-requests-pfizer-update-zoloft-label/</loc>
		<lastmod>2015-09-28T17:55:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/09/invokana-targeted-canadian-class-action-lawsuit/</loc>
		<lastmod>2015-09-30T16:04:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/bellwether-trials-scheduled-xarelto-coordinated-litigation/</loc>
		<lastmod>2015-10-02T13:27:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/expose-reveals-how-risperdal-became-blockbuster-drug/</loc>
		<lastmod>2015-10-05T18:58:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/kentucky-plaintiffs-blame-zofran-newborn-death/</loc>
		<lastmod>2015-10-07T18:07:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/couple-files-lawsuit-alleging-severe-complications-androgel/</loc>
		<lastmod>2015-10-09T17:41:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/california-parents-file-zofran-lawsuit-against-gsk/</loc>
		<lastmod>2015-10-14T18:00:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/fresenius-sued-plaintiff-suffers-fatal-cardiopulmonary-arrest/</loc>
		<lastmod>2015-10-20T17:20:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/zofran-lawsuits-consolidated-multidistrict-litigation/</loc>
		<lastmod>2015-10-20T17:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/confidential-resolution-reached-las-vegas-actos-trial/</loc>
		<lastmod>2015-10-21T18:29:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/new-study-highlights-ketoacidosis-risk-invokana-patients/</loc>
		<lastmod>2015-10-23T19:12:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/judge-remands-talc-lawsuits-state-court/</loc>
		<lastmod>2015-10-26T16:55:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/10/fda-accused-lax-oversight-pradaxa-approval-process/</loc>
		<lastmod>2015-10-30T15:35:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/fda-declines-approval-new-combination-diabetes-drug/</loc>
		<lastmod>2015-11-03T08:46:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/testosterone-lawsuit-alleges-hormone-therapy-led-heart-attack/</loc>
		<lastmod>2015-11-04T19:18:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/louisiana-mother-blames-zofran-sons-heart-condition/</loc>
		<lastmod>2015-11-06T17:15:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/androgel-lawsuits-identified-bellwether-trial-pool/</loc>
		<lastmod>2015-11-09T16:21:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/invokana-ketoacidosis-risk-seen-type-1-diabetics/</loc>
		<lastmod>2015-11-13T16:48:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/maryland-man-receives-1-75-million-risperdal-verdict/</loc>
		<lastmod>2015-11-16T18:57:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/hundreds-yaz-lawsuits-resolved-settlements/</loc>
		<lastmod>2015-11-18T17:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/plaintiff-blames-invokana-severe-kidney-damage/</loc>
		<lastmod>2015-11-20T23:06:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/status-conference-scheduled-granuflo-naturalyte-mdl/</loc>
		<lastmod>2015-11-23T21:49:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/11/diabetic-ketoacidosis-prompts-invokana-lawsuit/</loc>
		<lastmod>2015-11-26T04:59:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/plaintiff-demands-compensation-life-threatening-invokana-complications/</loc>
		<lastmod>2015-12-02T14:27:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/lawsuit-alleges-kidney-damage-invokana-use/</loc>
		<lastmod>2015-12-07T20:30:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/zofran-lawsuit-alleges-drug-causes-devastating-irreversible-life-long-consequences/</loc>
		<lastmod>2015-12-07T23:18:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/20-year-old-woman-files-zofran-complaint/</loc>
		<lastmod>2015-12-09T20:30:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/several-claims-added-xarelto-mdl/</loc>
		<lastmod>2015-12-14T00:13:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/fda-issues-warning-sglt2-inhibitor-side-effects/</loc>
		<lastmod>2015-12-14T22:53:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/january-status-conference-set-nj-talc-mcl/</loc>
		<lastmod>2015-12-16T18:05:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/fda-approval-xarelto-have-been-based-false-data/</loc>
		<lastmod>2015-12-18T21:51:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/jury-awards-plaintiff-1-75-million-risperdal-lawsuit/</loc>
		<lastmod>2015-12-21T17:36:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/bellwether-trials-for-androgel-litigation-set-for-2017/</loc>
		<lastmod>2015-12-23T23:31:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2015/12/judge-stipulates-xarelto-injury-types-bellwether-trials/</loc>
		<lastmod>2015-12-30T07:10:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/antidepressants-during-pregnancy-boosts-autism-risk-study-shows/</loc>
		<lastmod>2016-01-04T16:46:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/new-report-warns-21st-century-cures-act-shortfalls/</loc>
		<lastmod>2016-01-04T22:07:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/study-suggests-xarelto-presents-greater-risk-kidney-patients/</loc>
		<lastmod>2016-01-06T21:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/plaintiff-argues-zofran-caused-sons-heart-defect/</loc>
		<lastmod>2016-01-08T20:38:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/kentucky-settles-risperdal-litigation-15-5-million/</loc>
		<lastmod>2016-01-11T22:45:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/mother-demands-labeling-changes-zofran/</loc>
		<lastmod>2016-01-14T02:31:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/invokana-lawsuit-filed-alabama-district-court/</loc>
		<lastmod>2016-01-18T14:52:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/gsk-files-motion-dismiss-zofran-birth-defect-claims/</loc>
		<lastmod>2016-01-18T20:33:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/study-examines-causal-relationship-paxil-birth-defects/</loc>
		<lastmod>2016-01-20T23:21:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/124-million-risperdal-verdict-stands-supreme-court-rejects-appeal/</loc>
		<lastmod>2016-01-22T14:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/report-highlights-risks-newer-diabetes-drugs/</loc>
		<lastmod>2016-01-25T19:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/government-office-expresses-concern-fda-drug-oversight/</loc>
		<lastmod>2016-01-27T19:52:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/01/couple-files-mesothelioma-lawsuit-against-colgate-pfizer/</loc>
		<lastmod>2016-01-29T14:54:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/02/testosterone-claim-involving-testim-joins-mdl-2545/</loc>
		<lastmod>2016-02-01T21:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/02/study-suggests-risperdal-boosts-childhood-diabetes-risk/</loc>
		<lastmod>2016-02-03T11:30:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/02/oregon-mother-claims-zofran-caused-babys-cleft-palate/</loc>
		<lastmod>2016-02-06T05:55:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/02/xarelto-mdl-continues-grow/</loc>
		<lastmod>2016-02-16T21:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/02/jj-hit-72-million-judgement-talc-cancer-lawsuit/</loc>
		<lastmod>2016-02-25T17:10:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/03/fresenius-announces-250-million-granuflo-settlement/</loc>
		<lastmod>2016-03-02T02:56:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/03/fda-questions-safety-study-xarelto-approval/</loc>
		<lastmod>2016-03-15T19:10:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/04/parents-blame-zofran-sons-heart-defects/</loc>
		<lastmod>2016-04-12T17:41:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/05/jj-ordered-pay-55-million-talc-cancer-verdict/</loc>
		<lastmod>2016-05-09T17:40:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/05/fda-invokana-study-finds-potential-amputation-link/</loc>
		<lastmod>2016-05-25T20:14:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/06/new-study-highlights-nexium-dangers/</loc>
		<lastmod>2016-06-07T16:11:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/06/talcum-powder-blamed-deaths-recent-lawsuit/</loc>
		<lastmod>2016-06-17T13:44:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/06/woman-files-taxotere-lawsuit-hair-loss/</loc>
		<lastmod>2016-06-28T19:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/07/ismp-report-emphasizes-high-incidence-xarelto-injuries/</loc>
		<lastmod>2016-07-13T19:34:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/07/teen-receives-70-million-verdict-risperdal-lawsuit/</loc>
		<lastmod>2016-07-26T20:28:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/08/invokana-lawsuit-alleges-use-drug-led-dangerous-medical-condition/</loc>
		<lastmod>2016-08-10T17:41:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/08/early-trials-selected-growing-androgel-lawsuits/</loc>
		<lastmod>2016-08-24T16:03:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/09/plaintiff-alleges-jjs-talc-caused-cancer-age-24/</loc>
		<lastmod>2016-09-08T19:21:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/09/claimant-seeks-class-action-status-talc-lawsuit/</loc>
		<lastmod>2016-09-23T18:44:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/10/invokana-lawsuit-claims-diabetes-drug-caused-kidney-failure/</loc>
		<lastmod>2016-10-06T14:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/10/taxotere-lawsuits-centralized-multidistrict-litigation/</loc>
		<lastmod>2016-10-20T17:51:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/10/studies-cast-doubt-testosterone-benefits/</loc>
		<lastmod>2016-11-02T18:36:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2016/12/filing-streamlined-abilify-gambling-addiction-claims/</loc>
		<lastmod>2017-02-07T16:40:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/01/first-steps-commence-in-invokana-litigation/</loc>
		<lastmod>2017-02-07T16:34:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/02/johnson-johnson-denied-request-to-move-cancer-lawsuits-from-st-louis/</loc>
		<lastmod>2017-02-09T19:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/03/study-says-testosterone-replacement-therapy-increases-heart-attack-stroke-danger/</loc>
		<lastmod>2017-03-07T01:07:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/03/more-than-850-lawsuits-filed-over-taxotere-alleging-a-link-between-cancer-drug-and-hair-loss/</loc>
		<lastmod>2017-03-30T16:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/04/federal-farxiga-lawsuits-consolidated-in-ny/</loc>
		<lastmod>2017-04-21T02:24:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/05/dangerous-nexium-and-prevacid-side-effects-concealed-by-drug-maker-idaho-man-claims/</loc>
		<lastmod>2017-05-13T00:48:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/05/massive-110-million-verdict-for-talc-powder-plaintiff/</loc>
		<lastmod>2017-05-23T23:18:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/06/androgel-bellwether-trial-ruling-favors-plaintiffs/</loc>
		<lastmod>2017-06-07T15:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/06/invokana-lawsuit-alleges-drug-caused-urosepsis/</loc>
		<lastmod>2017-06-30T01:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/07/xarelto-and-similar-drugs-caused-more-than-3000-deaths-last-year/</loc>
		<lastmod>2017-07-20T22:14:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/08/nexium-other-ppi-lawsuits-consolidated/</loc>
		<lastmod>2017-08-18T02:27:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/09/juries-continue-to-find-in-favor-of-plaintiffs-in-talc-powder-lawsuits/</loc>
		<lastmod>2017-09-29T16:36:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/10/xarelto-stroke-study-stopped-because-results-indicate-high-bleeding-rates/</loc>
		<lastmod>2017-10-26T18:32:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/11/judge-orders-settlement-talks-after-large-jury-verdicts-in-androgel-lawsuits/</loc>
		<lastmod>2017-11-08T00:16:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2017/12/xarelto-makers-ordered-to-pay-27-8-million-for-failure-to-warn-about-risks/</loc>
		<lastmod>2017-12-14T17:08:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/01/400-testosterone-therapy-lawsuits-resolved-with-global-settlement/</loc>
		<lastmod>2018-01-11T16:48:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/02/number-of-taxotere-lawsuits-reaches-7500/</loc>
		<lastmod>2018-02-09T18:55:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/03/lawsuit-alleges-amputation-life-threatening-complications-from-invokana/</loc>
		<lastmod>2018-03-17T00:50:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/04/117-million-awarded-in-talc-powder-mesothelioma-case/</loc>
		<lastmod>2018-04-21T15:56:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/05/trial-dates-requested-for-nexium-prilosec-mdl-lawsuits/</loc>
		<lastmod>2018-05-11T17:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/06/talcum-powder-trial-to-begin-soon-in-missouri/</loc>
		<lastmod>2018-06-15T20:23:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/07/500-androderm-lawsuits-may-be-resolved-soon/</loc>
		<lastmod>2018-07-13T19:38:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/08/settlement-finalized-for-androderm-testosterone-lawsuits/</loc>
		<lastmod>2018-08-09T05:49:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/09/fda-issues-new-warning-for-invokana-diabetes-drugs/</loc>
		<lastmod>2018-09-07T20:13:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/10/talc-lawsuit-updates-recent-mistrial-cancer-expert-testimony/</loc>
		<lastmod>2018-10-12T20:53:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2018/11/mdl-centralization-sought-for-valsartan-litigation/</loc>
		<lastmod>2018-11-14T21:57:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2019/01/lawsuit-claims-zostavax-shingles-vaccine-caused-vision-problems/</loc>
		<lastmod>2019-01-22T16:59:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2019/02/plaintiff-claims-talc-powder-caused-her-ovarian-cancer/</loc>
		<lastmod>2019-02-25T23:40:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2019/09/bellwether-selection-for-nexium-prilosec-lawsuits-stalls/</loc>
		<lastmod>2019-10-07T22:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://drugreporter.com/2019/11/study-testosterone-therapy-raises-the-risk-of-blood-clots/</loc>
		<lastmod>2019-12-12T21:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
</urlset><!-- Request ID: f34d59a50aafac44945e4e3f7956bd86; Queries for sitemap: 262; Total queries: 335; Seconds: 0.06; Memory for sitemap: 2MB; Total memory: 80MB -->
